Pressmeddelanden, rapporter och bolagsmeddelande för Cessatech
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: CESSATECH ANNOUNCES THAT MANAGEMENT AND BOARD HAVE EXERCISED ALL THEIR WARRANTS OF SERIES TO2
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: CESSATECH ANNOUNCES THAT MANAGEMENT AND BOARD HAVE EXERCISED ALL THEIR WARRANTS OF SERIES TO2
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: CESSATECH ANNOUNCES THE START OF THE EXERCISE PERIOD FOR WARRANTS OF SERIES TO2
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: CESSATECH ANNOUNCES TO2 WARRANT EXERCISE PRICE AND START OF EXERCISE PERIOD
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Q&A session related topline data Study 0205
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Cessatech announces positive topline data from study 0205 with its lead candidate CT001 for the treatment of pain in children supporting further advancement of CT001
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Third Quarter Report Q3-2023
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Cessatech announces that the Paediatric Committee has agreed to a 50% reduction of the required number of patients in the final study of its nasal spray for the treatment of acute pain in children
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Cessatech announces last participant dosed in pivotal trial 0205 with lead candidate CT001
Spotlight News
Nyhetsuppdatering från Cessatech
Press release from Companies: Cessatech announces agreement with the European Medicines Agency on a Paediatric Investigational Plan for its second asset CT002 for medical procedural sedation in children